2023-11-072023-11-072008-12Özdemir vd. (2008). "Warfarin-induced chest wall and breast hematoma in an elderly female patient with atrial fibrillation: Original image". Turkiye Klinikleri Journal of Medical Sciences, 28(6), 992-994.1300-02922146-9040http://hdl.handle.net/11452/34786Atrial fibrillation is the most common sustained cardiac rhythm disorder. Current treaatment guidelines recommend long-term oral anticoagulation with a vitamin K antagonist, such as warfarin, in patients with atrial fibrillation who are at moderate to high risk of stroke. Bleeding is a common side effect of warfarin. The risk of severe bleeding is a small but definite (1-2% annually) result of warfarin use. Risk of bleeding is augmented if the international normalization ratio (INR) is high. We presented a case with warfarin induced chest wall and breast hematoma, which is a rare condition.eninfo:eu-repo/semantics/closedAccessGeneral & internal medicineWarfarinHematomaMulticenterArticle0002623836000332-s2.0-60249086964992994286Medicine, general & internalHematoma; Mouth Floor; Airway ObstructionFresh frozen plasmaVitamin K groupWarfarinAgedArticleBleedingBreastBreast engorgementBreast hematomaBreast tendernessCase reportChest wall hematomaComputer assisted tomographyDrug withdrawalEchographyFemaleHeart atrium fibrillationHemoglobin analysisHumanHuman tissueInternational normalized ratioMuscle hematomaPartial thromboplastin timePhysical examinationSkin discolorationSurgical techniqueThorax wall